Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 19 - Issue 7 - July, 2007

Feature

Original Contribution
Interatrial Septal Defect Closure for Cerebrovascular Accidents:
Exploring the Role of Various Anticoagulants
08/01/2008
Nicolas W. Shammas, MD, MS, Eric J. Dippel, MD, Ghassan Harb, Stephanie Egts, *Michael Jerin, PhD, Penny Stoakes, RN, Jeannette Byrd, RN, Gail A. Shammas, RN, Peter Sharis, MD
Nicolas W. Shammas, MD, MS, Eric J. D...
Interatrial septal defects (IASD) have been associated with an increased incidence of cryptogenic strokes.1–7 Percutaneous closure of these defects is now widely performed and the safety of this procedure has been established. It is unclear,...
Interatrial septal defects (IASD) have been associated with an increased incidence of cryptogenic strokes.1–7 Percutaneous closure of these defects is now widely performed and the safety of this procedure has been established. It is unclear,...
Interatrial septal defects...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Giant Coronary Aneurysm following Drug-Eluting Stent
Implantation Presenting as Fever of Unknown Origin
08/01/2008
Rajesh K. Jindal, MD, Rupesh George, MD, Balbir Singh, MD
Rajesh K. Jindal, MD, Rupesh George, ...
Introduction of drug-eluting stent (DES) has led to a marked reduction in the problem of in-stent restenosis across all patient subsets and lesions complexities.7 Recently, several case reports of aneurysm formation after DES implantation...
Introduction of drug-eluting stent (DES) has led to a marked reduction in the problem of in-stent restenosis across all patient subsets and lesions complexities.7 Recently, several case reports of aneurysm formation after DES implantation...
Introduction of drug-eluting...
08/01/2008
Journal of Invasive Cardiology
Case Report
Multivessel Coronary Vasospasm Mimicking Triple-Vessel
Obstructive Coronary Artery Disease
08/01/2008
Vineeta Ahooja, MD and Deepak Thatai, MD
Vineeta Ahooja, MD and Deepak Thatai,...
Variant angina is a distinct clinical entity first described by Prinzmetal and associates in 1959.1 The classic presentation is characterized by chest pain occurring at rest, and is more frequent in young women. Unlike true angina, the chest...
Variant angina is a distinct clinical entity first described by Prinzmetal and associates in 1959.1 The classic presentation is characterized by chest pain occurring at rest, and is more frequent in young women. Unlike true angina, the chest...
Variant angina is a distinct...
08/01/2008
Journal of Invasive Cardiology
Case Report
Massive Air Embolus Treated with Rheolytic Thrombectomy
08/01/2008
*§Basil M. Dudar, MD and §Henry E. Kim, MD, MPH
*§Basil M. Dudar, MD and §Henry E. ...
Rupture of atherosclerotic plaque leading to exposure of highly thrombogenic material to the blood pool with subsequent thrombus formation is the principal mechanism associated with acute coronary syndromes.1,2 Percutaneous coronary...
Rupture of atherosclerotic plaque leading to exposure of highly thrombogenic material to the blood pool with subsequent thrombus formation is the principal mechanism associated with acute coronary syndromes.1,2 Percutaneous coronary...
Rupture of atherosclerotic...
08/01/2008
Journal of Invasive Cardiology
Case Report
Iatrogenic Fistula between the Left Anterior Descending Coronary
Artery and Anterior Interventricular Vein following Stenting
08/01/2008
Ziad Elghoul, MD and Massoud A. Leesar, MD
Ziad Elghoul, MD and Massoud A. Leesa...
Coronary artery fistulae are uncommon vascular anomalies. The incidence of these anomalies is low, ranging from 0.2 to 0.25%.1 The fistulae frequently drain into one of the ventricles, the pulmonary arteries, the coronary sinus and the...
Coronary artery fistulae are uncommon vascular anomalies. The incidence of these anomalies is low, ranging from 0.2 to 0.25%.1 The fistulae frequently drain into one of the ventricles, the pulmonary arteries, the coronary sinus and the...
Coronary artery fistulae are...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
A Three-Dimensional Intravascular Ultrasound Comparison
between the New Zotarolimus-Eluting Stent (ZoMaxx‚Ñ¢) and
the Non-Drug-E
08/01/2008
Leandro I. Lasave, MD, Jose de Ribamar Costa, Jr., MD, Alexandre A. Abizaid, MD, PhD, Fausto Feres, MD, PhD, Luiz F. Tanajura, MD, PhD, Rodolfo Staico, MD, Andrea A. Abizaid, MD, PhD, Pedro Beraldo, MD, Amanda M.R. Sousa, MD, PhD, J. Eduardo M.R. Sousa, MD, PhD
Leandro I. Lasave, MD, Jose de Ribama...
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention Reduces Ischemic Events without Affecting the Need
08/01/2008
Sorin J. Brener, MD, Steven R. Steinhubl, MD, Peter B. Berger, MD, Danielle M. Brennan, MS, Eric J. Topol, MD, for the CREDO Investigators
Sorin J. Brener, MD, Steven R. Steinh...
When clopidogrel is added to background aspirin therapy, it reduces the composite of cardiovascular death, myocardial infarction (MI) or stroke in patients with acute coronary syndromes (ACS)1 or percutaneous revascularization.2 The most...
When clopidogrel is added to background aspirin therapy, it reduces the composite of cardiovascular death, myocardial infarction (MI) or stroke in patients with acute coronary syndromes (ACS)1 or percutaneous revascularization.2 The most...
When clopidogrel is added to...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
The Influence of Low (81 mg) versus High (325 mg) Doses of
ASA on the Incidence of Sirolimus-Eluting Stent Thrombosis
08/01/2008
Dominique Joyal, MD, Jeffrey H. Freihage, MD, Kevin Cohoon, MD, Michael Tempelhof, MD, Ferdinand Leya, MD, Robert S. Dieter, MD, Lowell Steen, MD, Bruce Lewis, MD, Dinesh Arab, MD
Dominique Joyal, MD, Jeffrey H. Freih...
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Transcatheter Closure of Small-to-Large Patent Ductus Arteriosus
with Different Devices: Queries and Challenges
08/01/2008
Mehnaz Atiq, MD, Nadeem Aslam, MD, *Khawar A Kazmi, MD
Mehnaz Atiq, MD, Nadeem Aslam, MD, *K...
Patent ductus arteriosus (PDA) can cause congestive cardiac failure, repeated pneumonia, pulmonary hypertension and an increased risk for endocarditis. Transcatheter closure of PDA is currently the preferred therapeutic alternative to...
Patent ductus arteriosus (PDA) can cause congestive cardiac failure, repeated pneumonia, pulmonary hypertension and an increased risk for endocarditis. Transcatheter closure of PDA is currently the preferred therapeutic alternative to...
Patent ductus arteriosus (PDA)...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Percutaneous Closure of Patent Ductus Arteriosus: State of the Art
08/01/2008
P. Syamasundar Rao, MD
P. Syamasundar Rao, MD
Patent ductus arteriosus (PDA) may be an isolated lesion or may be present in association with other defects. Isolated PDA constitutes 6–11% of all congenital heart defects. The configuration of PDA varies considerably, but most often it has...
Patent ductus arteriosus (PDA) may be an isolated lesion or may be present in association with other defects. Isolated PDA constitutes 6–11% of all congenital heart defects. The configuration of PDA varies considerably, but most often it has...
Patent ductus arteriosus (PDA)...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

July 2007 Volume 19 Issue 7

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement